 |
Anteo Diagnostics Ltd (AXS:ADO) has proprietary commercial processes that provide performance, and/or manufacturing benefits to a broad array of life science applications. Our expertise is in surface coating technology which enables the design of improved, cheaper diagnostic tests as well as efficient separations/purifications products, amongst other applications.
|
|
 |
Building PartnershipsAnteo's initial focus is to supply its products and processes to industry partners to enhance capabilities to rapidly develop diagnostics and research assays for the pathology laboratory and point-of-care markets. Our model is to enter supply or royalty-based agreements with appropriate third parties and, where appropriate, to assist our partners to develop products under research collaboration arrangements.
|
|
Wholesale Investor Interview Link Down
19/12/2010
Wholesale Investor Report on ADO
02/12/2010
Geoff Cumming (CEO) Interviewed
01/12/2010
Anteo Diagnostics Featured in Fin Review
13/11/2010
Dear Shareholder,
We would like to be able to provide regular updates on our activities by email and posting on our website. To assist us in compiling a list of email addresses for shareholders and interested parties we would appreciate you
completing the details below.
|
